SMITHS FALLS, ON, Sept. 18, 2017 /CNW/ - Canopy Growth Corporation
(TSX:WEED) ("Canopy Growth" or "the Corporation") today announced
that all of management's nominees listed in its August 11, 2017 management information circular
were elected as directors of the Corporation at Canopy Growth's
September 15, 2017 annual general and
special meeting of shareholders (the "Annual Meeting"). The
detailed results of the vote for the election of directors held at
the Annual Meeting are set out below.
Nominee
|
Votes For
|
% Votes
For
|
Votes
Withheld
|
% Votes
Withheld
|
John K.
Bell
|
20,538,945
|
98.65
|
280,528
|
1.35
|
Murray
Goldman
|
18,697,708
|
89.81
|
2,121,765
|
10.19
|
Bruce
Linton
|
19,003,280
|
91.28
|
1,816,193
|
8.72
|
Chris
Schnarr
|
20,259,887
|
97.31
|
559,586
|
2.69
|
Peter E.
Stringham
|
20,284,654
|
97.43
|
534,819
|
2.57
|
In addition, shareholders approved the Employee Stock Purchase
Plan ("ESPP") and the Omnibus Incentive Plan ("OIP") as described
in the Corporation's August 11, 2017
management information circular. The detailed results of the
votes for the ESPP and OIP held at the Annual Meeting are provided
below.
Special
Item
|
Votes For
|
% Votes
For
|
Votes
Against
|
% Votes
Against
|
ESPP
|
20,393,966
|
97.96
|
425,507
|
2.04
|
OIP
|
18,336,277
|
88.07
|
2,483,195
|
11.93
|
Canopy Growth also confirmed that shareholders approved the
appointment of Deloitte LLP, Chartered Accountants, as the
Corporation's auditors.
ABOUT CANOPY GROWTH CORPORATION
Canopy Growth is a
world-leading diversified cannabis company, offering distinct
brands and curated cannabis varieties in dried, oil and capsule
forms. Through its wholly-owned subsidiaries, Canopy Growth
operates numerous state-of-the-art production facilities with over
half a million square feet of GMP-certified indoor and greenhouse
production capacity, all to an unparalleled level of quality
assurance procedures and testing. Canopy Growth has established
partnerships with leading sector names in Canada and abroad, with interests and
operations spanning four continents. The Company is proudly
dedicated to educating healthcare practitioners, providing
consistent access to high quality cannabis products, conducting
robust clinical research, and furthering the public's understanding
of cannabis. For more information visit www.canopygrowth.com.
SOURCE Canopy Growth Corporation